Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.10 CNY
2.02 B CNY
7.36 B CNY
499.92 M
About HANGZHOU TIGERMED
Sector
CEO
Xiao Chun Cao
Website
Headquarters
Hangzhou
Founded
2004
ISIN
CNE100001KV8
FIGI
BBG002QKZ361
Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is headquartered in Hangzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 300347 is 66.08 CNY — it has decreased by −2.00% in the past 24 hours. Watch HANGZHOU TIGERMED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange HANGZHOU TIGERMED stocks are traded under the ticker 300347.
300347 stock has risen by 5.53% compared to the previous week, the month change is a −10.28% fall, over the last year HANGZHOU TIGERMED has showed a −6.76% decrease.
We've gathered analysts' opinions on HANGZHOU TIGERMED future price: according to them, 300347 price has a max estimate of 85.00 CNY and a min estimate of 26.05 CNY. Watch 300347 chart and read a more detailed HANGZHOU TIGERMED stock forecast: see what analysts think of HANGZHOU TIGERMED and suggest that you do with its stocks.
300347 reached its all-time high on Jul 1, 2021 with the price of 209.41 CNY, and its all-time low was 3.92 CNY and was reached on Aug 17, 2012. View more price dynamics on 300347 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
300347 stock is 4.70% volatile and has beta coefficient of 1.48. Track HANGZHOU TIGERMED stock price on the chart and check out the list of the most volatile stocks — is HANGZHOU TIGERMED there?
Today HANGZHOU TIGERMED has the market capitalization of 56.91 B, it has decreased by −4.33% over the last week.
Yes, you can track HANGZHOU TIGERMED financials in yearly and quarterly reports right on TradingView.
HANGZHOU TIGERMED is going to release the next earnings report on Mar 31, 2025. Keep track of upcoming events with our Earnings Calendar.
300347 earnings for the last quarter are 0.37 CNY per share, whereas the estimation was 0.54 CNY resulting in a −30.85% surprise. The estimated earnings for the next quarter are 0.55 CNY per share. See more details about HANGZHOU TIGERMED earnings.
HANGZHOU TIGERMED revenue for the last quarter amounts to 1.71 B CNY, despite the estimated figure of 2.02 B CNY. In the next quarter, revenue is expected to reach 1.99 B CNY.
300347 net income for the last quarter is 320.58 M CNY, while the quarter before that showed 257.78 M CNY of net income which accounts for 24.36% change. Track more HANGZHOU TIGERMED financial stats to get the full picture.
Yes, 300347 dividends are paid annually. The last dividend per share was 0.57 CNY. As of today, Dividend Yield (TTM)% is 0.86%. Tracking HANGZHOU TIGERMED dividends might help you take more informed decisions.
HANGZHOU TIGERMED dividend yield was 1.03% in 2023, and payout ratio reached 24.11%. The year before the numbers were 0.51% and 22.82% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 300347 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANGZHOU TIGERMED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HANGZHOU TIGERMED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HANGZHOU TIGERMED stock shows the neutral signal. See more of HANGZHOU TIGERMED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.